Suppr超能文献

接受环磷酰胺治疗的犬骨髓移植受者的细胞介导免疫

Cell-mediated immunity in canine marrow graft recipients given cyclophosphamide.

作者信息

Abb J, Kolb H J, Grosse-Wilde H, Reider I, Thierfelder S

出版信息

Exp Hematol. 1978 Jan;6(1):58-66.

PMID:146607
Abstract

The cellular immune status of 48 canine chimeras was studied between 15 days and 3 years after a lethal dose of cyclophosphamide (CY) and an allogeneic marrow graft. Marrow graft recipients were given no further immuno-suppressive treatment. Recovery of total white blood cell counts was complete by day 20 after grafting. Peripheral blood lymphocyte counts did not reach the normal range until day 100. Short-term chimeras (less than 100 days postgrafting) showed marked impairment of cell-mediated immunity as indicated by the inability to respond adequately to nonspecific mitogenic (PHA, ConA, PWM) and specific antigenic (allogeneic lymphocytes, PPD) stimulation in vitro. Skin test reactivity to PPD after immunization with BCG was also significantly depressed. Long-term chimeras (more than 100 days postgrafting) had normal in vitro response to mitogens; lymphocyte blastogenesis to specific antigens however remained decreased for prolonged periods postgrafting. The survival time at first set allogeneic skin grafts showed no significant difference between chimeras and normal control dogs. Lymphocyte transformation in response to stimulation with specific antigens may prove a useful parameter for the in vitro evaluation of defects in cellular immune reactivity following allogeneic marrow transplantation.

摘要

对48只犬嵌合体在给予致死剂量的环磷酰胺(CY)和同种异体骨髓移植后15天至3年期间的细胞免疫状态进行了研究。骨髓移植受者未接受进一步的免疫抑制治疗。移植后第20天白细胞总数恢复正常。外周血淋巴细胞计数直到第100天才达到正常范围。短期嵌合体(移植后少于100天)表现出细胞介导免疫的明显受损,体外对非特异性有丝分裂原(PHA、ConA、PWM)和特异性抗原(同种异体淋巴细胞、PPD)刺激无法做出充分反应即表明了这一点。用卡介苗免疫后对PPD的皮肤试验反应性也显著降低。长期嵌合体(移植后超过100天)对有丝分裂原的体外反应正常;然而,移植后很长一段时间内,对特异性抗原的淋巴细胞增殖仍持续降低。首次进行同种异体皮肤移植时,嵌合体和正常对照犬的存活时间没有显著差异。对特异性抗原刺激的淋巴细胞转化可能是体外评估同种异体骨髓移植后细胞免疫反应缺陷的一个有用参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验